Moderators:
Search This Board: 
Created: 03/19/2014 12:15:57 PM - Followers: 151 - Board type: Free - Posts Today: 2
About EastGate Biotech
EastGate Biotech focuses on innovative technological developments and produces and distributes innovative drug compounds and healthy nutraceuticals that are based on natural therapies absorbed by the body.

We utilize advanced nanotechnologies and alternative delivery systems that take difficult to deliver compounds and deliver them using our nanotechnology platform which ultimately increase the bioavailability to the body.

Using our methods of delivery provides healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain a healthy lifestyle.

EastGate's wholly owned subsidiary Omni Surgery and Anti-Aging Centre is the first of many surgery centers to come under the Omni umbrella as we plan to roll up existing business under the Omni brand and expand our footprint globally.



   


 

  •  

Contact Information
2203-65 Harbour Square
Toronto, ONT M5J 2L4
Canada
www.eastgatebiotech.com(647) 692-0652info@eastgatepharmaceuticals.com



Share Structure 

Market Cap Market Cap     
1,904,143
05/03/2021

Authorized Shares   
3,000,000,000     
05/03/2021
 
Outstanding Shares
1,057,857,377
05/03/2021

Shareholders of Record
170
08/15/2020

















ETBI patents:

US 61/947,678 Title: Pharmaceutical Composition for Transmucosal Delivery

US 61/947,698 Title: Treatment of Diabetes and Metabolic Syndrome

PCT/C2014/000126 Title: Pharmaceutical Composition for Transmucosal Administration of Benzodiazepines

PCT/CA2014/000127 Title: Pharmaceutical Composition For Enhanced Transmucosal Administration of Benzodiazepines




MOST RECENT NEWS: May 17th, 2021

**EastGate Biotech Corp. Enters Into a 3-way International Distribution Agreement With Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc.**

WEST CALDWELL, NJ and TORONTO, ON, May 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- EastGate Biotech Corp. (OTC: Expert Markets: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes, announced today that the company has entered into a three-way international distribution agreement with Dr. Upadhyay Vedic Research Laboratories of India and US-based ImmunoJuvenate Inc. for the marketing of Vedic Research Laboratories’ natural and ayurvedic product catalogue. While the marketing agreement will initially focus on Vedic’s immunity-boosting product it will expand to seven other products serving other treatment areas.  READ MORE
 

**EastGate strikes licensing and distribution deal for Glucora** 

WEST CALDWELL, NJ and TORONTO, ON, March 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – EastGate Biotech Corp. (Other Markets OTC: Expert Markets: ETBI), a pharmaceutical company, that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes, announced today that the company has entered into a licensing and distribution agreement with Stenergy LLC and Butero Farms for the company’s nutraceutical product, Glucora. The licensing agreement includes a licensing fee of $3 million USD which will include a combination payment in cash and sales-driven funds.  READ MORE




 

Clinical and Scientific Highlights:  yes

Announced positive Phase II Clinical Results of Insugin, its liquid insulin mouth rinse for Type 2 diabetes patients in Pakistan
Preparation underway for the Phase III Clinical Study of Insugin in Pakistan
Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply;  the terms include free API insulin to be provided to EastGate Biotech for all clinical studies of Insugin
Expands and restructures Joint Venture with its partner in Pakistan to focus on EastGate Biotech as a brand.  The key products of the Joint Venture to be tested, registered and marketed include Insugin for diabetes application, alternative insulin product for Alzheimer’s application and blood plasma-based products, Human Serum Albumin 20% for the Canadian market
Initiated plans to expand its alternative insulin delivery portfolio to apply to the treatment of Alzheimer’s Disease with a desired endpoint of delaying the progression of the disease which is measured in terms of memory loss and improvement in the status of self care  

Corporate Highlights: yes

  • Announced the appointment of Bill Abajian as Chief Operating Officer to lead licensing and Marketing Phase of the company’s developments
    Filed 2017 and 2018 Financial Reports

Anticipated Milestones: yes

  • Initiation and completion of Phase III study of Insugin in Pakistan
    Execute licensing agreements in other territories aiming to cover continents;  plan regulatory and clinical path for each of these markets
    Initiate a Proof of Concept study of an alternative insulin product for Alzheimer’s indication
    Plan registration of Human Serum Albumin 20% and regular recombinant human insulin in Canada
    Consider a secondary public listing
    Explore uplisting to a senior exchange

PRESS RELEASES 

https://seekingalpha.com/news/3670269-eastgate-strikes-licensing-and-distribution-deal-for-glucora?utm_source=otcmarkets&utm_medium=referral

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-pakistan-expands-its-collaboration-advancing-development-new-vaccine-against-covid-19/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-discusses-their-phase-3-clinical-trials-and-recent-coronavirus-agreement/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-pakistan-receives-international-marketing-rights-anaferon-approved-coronavirus-treatment-potentially-combat-wuh/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-provides-summary-2019-corporate-and-development-highlights/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-expands-pipeline-alzheimers-disease-using-its-alternative-insulin-delivery-platform/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-announces-expansion-and-restructuring-joint-venture-its-partner-pakistan/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-receives-regulatory-approval-initiate-phase-iii-90-day-clinical-trial-insugin-its-liquid-insulin-mouth-rinse-so/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-corp-otc-etbi-management-interview/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-announces-appointment-bill-abajian-lead-licensing-and-marketing-phase-chief-operating-officer/

http://www.eastgatebiotech.com/investors/press-releases/eastgate-biotech-files-application-initiate-phase-iii-clinical-trial-insugin/



   
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#14592
Still tracking and hoping they can turn it around! stolles8 06/28/2022 07:11:56 AM
#14591
Questions: - what’s the status of getting current? stolles8 06/28/2022 06:47:39 AM
#14590
Never reply? Are you demanding answers or Jimmy Swaggert 06/27/2022 10:24:02 AM
#14589
Where is this info coming from? They never stolles8 06/27/2022 09:25:35 AM
#14588
I heard they are working with otc markets Jimmy Swaggert 06/22/2022 10:06:28 AM
#14587
Any news of a turn? Slowmoe28 06/21/2022 02:43:25 PM
#14586
Any news of a turn? Slowmoe28 06/21/2022 02:43:23 PM
#14585
Uh huh. Right. Anyway, things are about to Jimmy Swaggert 05/31/2022 11:13:17 PM
#14584
You have all been scammed by these 3 vendor1 05/31/2022 07:36:41 PM
#14583
26,000 shares is better than zero shares I suppose. Jimmy Swaggert 04/15/2022 11:55:45 AM
#14582
https://www.linkedin.com/posts/nasir-irfat-31b98350_eastgate-biotech-pakistan-si gebla 02/03/2022 03:48:52 PM
#14581
These guys are cowards. vendor1 02/03/2022 12:02:01 AM
#14580
Buying coming in. What’s about to go down???? Jimmy Swaggert 12/30/2021 12:51:18 PM
#14579
I’m curious how long it will take for Jimmy Swaggert 12/23/2021 03:18:28 PM
#14578
hi Jw 02opida 12/20/2021 02:54:35 PM
#14577
Morning! Jimmy Swaggert 12/20/2021 01:34:03 PM
#14576
morning ETBI 02opida 12/20/2021 12:32:35 PM
#14575
Good, but not good enough. Jimmy Swaggert 12/10/2021 11:00:08 AM
#14574
Random tweets but nothing of substance. One mentioned stolles8 12/10/2021 08:51:58 AM
#14573
Has anyone heard anything? Jimmy Swaggert 12/09/2021 10:21:43 PM
#14572
Come on ETBI!!! Jimmy Swaggert 11/30/2021 04:19:29 PM
#14571
This has been showing green on TD since RussianBot 11/22/2021 09:43:16 AM
#14570
That’s positive!!! Can’t wait to see the Jimmy Swaggert 11/18/2021 05:31:34 PM
#14569
Twitter posts says Etbi and mjbiopharm still working stolles8 11/18/2021 10:07:26 AM
#14568
500,000 volume? RussianBot 11/12/2021 04:54:15 PM
#14567
It looks like a few q’s and an Jimmy Swaggert 10/28/2021 05:28:20 PM
#14566
Small trades recently. Maybe the company is getting Jimmy Swaggert 10/28/2021 05:26:46 PM
#14565
Me too! Hopeful but not expecting anything - stolles8 10/21/2021 08:17:59 AM
#14564
I agree 100%!!! I’ve been in this one Jimmy Swaggert 10/20/2021 06:23:04 PM
#14563
Etbi gonna make a lot of people happy! Thirdave 10/20/2021 04:35:23 PM
#14562
Wow! They actually called? That’s awesome. Jimmy Swaggert 10/20/2021 10:53:18 AM
#14561
Was nice seeing a $40k “increase” in my stolles8 10/20/2021 08:31:17 AM
#14560
This has been iffy for a while. Lol. Jimmy Swaggert 10/05/2021 02:35:35 PM
#14559
Don't understand the slow response. This is starting Slowmoe28 10/05/2021 09:08:00 AM
#14558
When they put out updated financials. Jimmy Swaggert 09/30/2021 02:27:48 PM
#14557
When does Etbi start trading again? Slowmoe28 09/30/2021 08:35:02 AM
#14556
When do etbi start trading again? Slowmoe28 09/30/2021 08:33:38 AM
#14555
Pink current is a few filings and ETBI Jimmy Swaggert 09/27/2021 03:44:35 PM
#14554
All the trades happen here. I’m sure it’s Jimmy Swaggert 09/17/2021 11:19:55 AM
#14553
Same here. They should hurry. We all have Jimmy Swaggert 09/02/2021 03:15:45 PM
#14552
Anxiously hoping to see financials and a PR stolles8 09/02/2021 10:09:05 AM
#14551
Same here. It used to trade around .04 Jimmy Swaggert 08/28/2021 11:47:58 AM
#14550
We hope! Should have cashed out when it stolles8 08/27/2021 06:21:18 PM
#14549
Right. You’ll have to wait until late September-October. Jimmy Swaggert 08/27/2021 11:46:20 AM
#14548
I would like to roll the dice with head22 08/26/2021 01:43:09 PM
#14547
Not if… When they submit. But my guess Jimmy Swaggert 08/26/2021 11:18:37 AM
#14546
If they submit financials to OTC we can stolles8 08/25/2021 05:48:58 PM
#14545
More accumulation. Love it. Jimmy Swaggert 08/25/2021 02:08:40 PM
#14544
I wouldn’t be surprised if this trades to Jimmy Swaggert 08/24/2021 02:02:32 PM
#14543
For whatever reason, the company always takes their Jimmy Swaggert 08/24/2021 02:01:03 PM
Post Subject